No Data
No Data
Optimistic Investors Push EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Up 28% But Growth Is Lacking
EyePoint Pharmaceuticals Price Target Announced at $18.00/Share by Scotiabank
EyePoint Pharmaceuticals Initiated at Sector Outperform by Scotiabank
Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating
Further Weakness as EyePoint Pharmaceuticals (NASDAQ:EYPT) Drops 12% This Week, Taking Five-year Losses to 54%
Capital One Financial Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $35
No Data
No Data